|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 101 to 200 out of 995 for Ace2

0.046s

Categories

Hits by Pathway

Hits by Strain

Hits by Category

Type Details Score
Publication
First Author: Li D
Year: 2022
Journal: J Med Virol
Title: Molecular imaging on ACE2-dependent transocular infection of coronavirus.
Volume: 94
Issue: 10
Pages: 4878-4889
Publication      
First Author: Zhou B
Year: 2020
Journal: bioRxiv
Title: SARS-CoV-2 spike D614G variant confers enhanced replication and transmissibility
Publication      
First Author: Sun SH
Year: 2020
Journal: Cell Host Microbe
Title: A Mouse Model of SARS-CoV-2 Infection and Pathogenesis.
Publication
First Author: Zhao MM
Year: 2021
Journal: Signal Transduct Target Ther
Title: Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development.
Volume: 6
Issue: 1
Pages: 134
Publication
First Author: Li C
Year: 2022
Journal: Cell
Title: Broad neutralization of SARS-CoV-2 variants by an inhalable bispecific single-domain antibody.
Volume: 185
Issue: 8
Pages: 1389-1401.e18
Publication
First Author: Zhou B
Year: 2021
Journal: Nature
Title: SARS-CoV-2 spike D614G change enhances replication and transmission.
Volume: 592
Issue: 7852
Pages: 122-127
Publication  
First Author: de Kloet AD
Year: 2020
Journal: Physiol Behav
Title: Overexpression of angiotensin converting enzyme 2 reduces anxiety-like behavior in female mice.
Volume: 224
Pages: 113002
Publication  
First Author: McMahon CL
Year: 2023
Journal: Brain Behav Immun
Title: Fetal brain vulnerability to SARS-CoV-2 infection.
Volume: 112
Pages: 188-205
Publication        
First Author: Shanghai Research Center for Model Organisms
Year: 2019
Title: Shanghai Research Center for Model Organisms Website
Publication
First Author: Liu MQ
Year: 2023
Journal: J Virol
Title: A SARS-CoV-2-Related Virus from Malayan Pangolin Causes Lung Infection without Severe Disease in Human ACE2-Transgenic Mice.
Volume: 97
Issue: 2
Pages: e0171922
Publication
First Author: Qi YF
Year: 2016
Journal: J Mol Med (Berl)
Title: Angiotensin-converting enzyme 2 inhibits high-mobility group box 1 and attenuates cardiac dysfunction post-myocardial ischemia.
Volume: 94
Issue: 1
Pages: 37-49
Publication  
First Author: Wang L
Year: 2016
Journal: Neuropharmacology
Title: Increasing brain angiotensin converting enzyme 2 activity decreases anxiety-like behavior in male mice by activating central Mas receptors.
Volume: 105
Pages: 114-123
Publication      
First Author: Wu X
Year: 2021
Journal: bioRxiv
Title: A potent bispecific nonobody protects hACE2 mice against SARS-CoV-2 infection via intranasal administration.
Publication
First Author: Wang LP
Year: 2016
Journal: Pflugers Arch
Title: Protective role of ACE2-Ang-(1-7)-Mas in myocardial fibrosis by downregulating KCa3.1 channel via ERK1/2 pathway.
Volume: 468
Issue: 11-12
Pages: 2041-2051
Publication
First Author: Yang XH
Year: 2012
Journal: Peptides
Title: Role of angiotensin-converting enzyme (ACE and ACE2) imbalance on tourniquet-induced remote kidney injury in a mouse hindlimb ischemia-reperfusion model.
Volume: 36
Issue: 1
Pages: 60-70
Publication  
First Author: Gao S
Year: 2023
Journal: Front Cardiovasc Med
Title: Endothelial SARS-CoV-2 infection is not the underlying cause of COVID-19-associated vascular pathology in mice.
Volume: 10
Pages: 1266276
Publication
First Author: Perico L
Year: 2023
Journal: Sci Rep
Title: SARS-CoV-2 spike protein induces lung endothelial cell dysfunction and thrombo-inflammation depending on the C3a/C3a receptor signalling.
Volume: 13
Issue: 1
Pages: 11392
Publication      
First Author: Ye Q
Year: 2020
Journal: bioRxiv
Title: SARS-CoV-2 infection causes transient olfactory dysfunction in mice.
Publication      
First Author: Chen J
Year: 2021
Journal: bioRxiv
Title: A live attenuated influenza virus-vectored intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2.
Publication      
First Author: Zhu L
Year: 2020
Journal: bioRxiv
Title: Double lock of a potent human monoclonal antibody against SARS-CoV-2.
Publication
First Author: Wu Y
Year: 2020
Journal: Science
Title: A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2.
Volume: 368
Issue: 6496
Pages: 1274-1278
Publication      
First Author: Pinto D
Year: 2020
Journal: bioRxiv
Title: Structural and functional analysis of a potent sarbecovirus neutralizing antibody.
Publication
First Author: Komatsu T
Year: 2002
Journal: DNA Seq
Title: Molecular cloning, mRNA expression and chromosomal localization of mouse angiotensin-converting enzyme-related carboxypeptidase (mACE2).
Volume: 13
Issue: 4
Pages: 217-20
SO Term
Publication
First Author: Niu MJ
Year: 2008
Journal: Endocrine
Title: Loss of angiotensin-converting enzyme 2 leads to impaired glucose homeostasis in mice.
Volume: 34
Issue: 1-3
Pages: 56-61
Publication  
First Author: Gu H
Year: 2016
Journal: Sci Rep
Title: Angiotensin-converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus.
Volume: 6
Pages: 19840
Publication    
First Author: van de Veerdonk FL
Year: 2020
Journal: Elife
Title: Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.
Volume: 9
Publication
First Author: Wang Q
Year: 2020
Journal: Cell
Title: Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2.
Volume: 181
Issue: 4
Pages: 894-904.e9
Publication
First Author: Zhang R
Year: 2019
Journal: Am J Physiol Lung Cell Mol Physiol
Title: MiRNA let-7b promotes the development of hypoxic pulmonary hypertension by targeting ACE2.
Volume: 316
Issue: 3
Pages: L547-L557
Publication
First Author: Gurumurthy CB
Year: 2020
Journal: Nat Protoc
Title: Genetically modified mouse models to help fight COVID-19.
Volume: 15
Issue: 12
Pages: 3777-3787
Publication
First Author: Ulrich L
Year: 2022
Journal: Nature
Title: Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not Beta.
Volume: 602
Issue: 7896
Pages: 307-313
Publication      
First Author: Ulrich L
Year: 2021
Journal: bioRxiv
Title: Enhanced fitness of SARS-CoV-2 variant of concern B.1.1.7, but not B.1.351, in animal models.
Publication
First Author: Barut GT
Year: 2022
Journal: Nat Commun
Title: The spike gene is a major determinant for the SARS-CoV-2 Omicron-BA.1 phenotype.
Volume: 13
Issue: 1
Pages: 5929
Publication      
First Author: Muñoz-Fontela C
Year: 2020
Journal: Nature
Title: Animal models for COVID-19.
Publication
First Author: Klempin F
Year: 2018
Journal: Cell Mol Life Sci
Title: Depletion of angiotensin-converting enzyme 2 reduces brain serotonin and impairs the running-induced neurogenic response.
Volume: 75
Issue: 19
Pages: 3625-3634
Publication
First Author: Lovren F
Year: 2008
Journal: Am J Physiol Heart Circ Physiol
Title: Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis.
Volume: 295
Issue: 4
Pages: H1377-84
Publication
First Author: Kuba K
Year: 2005
Journal: Nat Med
Title: A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury.
Volume: 11
Issue: 8
Pages: 875-9
Publication
First Author: Patel VB
Year: 2012
Journal: Hypertension
Title: Cardioprotective effects mediated by angiotensin II type 1 receptor blockade and enhancing angiotensin 1-7 in experimental heart failure in angiotensin-converting enzyme 2-null mice.
Volume: 59
Issue: 6
Pages: 1195-203
Publication
First Author: Cao X
Year: 2014
Journal: Mol Cell Endocrinol
Title: The ACE2/Ang-(1-7)/Mas axis can inhibit hepatic insulin resistance.
Volume: 393
Issue: 1-2
Pages: 30-8
Publication
First Author: Cao X
Year: 2019
Journal: Diabetes Metab Res Rev
Title: Angiotensin-converting enzyme 2 inhibits endoplasmic reticulum stress-associated pathway to preserve nonalcoholic fatty liver disease.
Volume: 35
Issue: 4
Pages: e3123
Publication  
First Author: Cao X
Year: 2016
Journal: Sci Rep
Title: Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis activates Akt signaling to ameliorate hepatic steatosis.
Volume: 6
Pages: 21592
Publication
First Author: Rey-Parra GJ
Year: 2012
Journal: J Mol Med (Berl)
Title: Angiotensin converting enzyme 2 abrogates bleomycin-induced lung injury.
Volume: 90
Issue: 6
Pages: 637-47
Publication
First Author: Lu CL
Year: 2014
Journal: Int J Mol Med
Title: The angiotensin-converting enzyme 2/angiotensin (1-7)/Mas axis protects the function of pancreatic β cells by improving the function of islet microvascular endothelial cells.
Volume: 34
Issue: 5
Pages: 1293-300
Publication  
First Author: Yuan L
Year: 2013
Journal: J Diabetes Res
Title: Angiotensin-Converting Enzyme 2 Deficiency Aggravates Glucose Intolerance via Impairment of Islet Microvascular Density in Mice with High-Fat Diet.
Volume: 2013
Pages: 405284
Publication
First Author: Tikellis C
Year: 2014
Journal: Am J Physiol Renal Physiol
Title: Angiotensin-converting enzyme 2 mediates hyperfiltration associated with diabetes.
Volume: 306
Issue: 7
Pages: F773-80
Publication  
First Author: Chen LJ
Year: 2016
Journal: Peptides
Title: Angiotensin-converting enzyme 2 ameliorates renal fibrosis by blocking the activation of mTOR/ERK signaling in apolipoprotein E-deficient mice.
Volume: 79
Pages: 49-57
Publication
First Author: Bernardi S
Year: 2012
Journal: Nephrol Dial Transplant
Title: High-salt diet increases glomerular ACE/ACE2 ratio leading to oxidative stress and kidney damage.
Volume: 27
Issue: 5
Pages: 1793-800
Publication  
First Author: Sun Y
Year: 2015
Journal: Part Fibre Toxicol
Title: Cationic nanoparticles directly bind angiotensin-converting enzyme 2 and induce acute lung injury in mice.
Volume: 12
Pages: 4
Publication  
First Author: Nakandakari-Higa S
Year: 2022
Journal: Front Immunol
Title: A minimally-edited mouse model for infection with multiple SARS-CoV-2 strains.
Volume: 13
Pages: 1007080
Publication
First Author: Takeshita H
Year: 2020
Journal: Hypertens Res
Title: Different effects of the deletion of angiotensin converting enzyme 2 and chronic activation of the renin-angiotensin system on muscle weakness in middle-aged mice.
Volume: 43
Issue: 4
Pages: 296-304
Publication
First Author: Inaba S
Year: 2011
Journal: J Hypertens
Title: Role of angiotensin-converting enzyme 2 in cardiac hypertrophy induced by nitric oxide synthase inhibition.
Volume: 29
Issue: 11
Pages: 2236-45
Publication
First Author: Gurley SB
Year: 2006
Journal: J Clin Invest
Title: Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice.
Volume: 116
Issue: 8
Pages: 2218-25
Publication  
First Author: Domenig O
Year: 2016
Journal: Sci Rep
Title: Neprilysin is a Mediator of Alternative Renin-Angiotensin-System Activation in the Murine and Human Kidney.
Volume: 6
Pages: 33678
Publication
First Author: Roca-Ho H
Year: 2020
Journal: Lab Invest
Title: Angiotensin-converting enzyme 2 influences pancreatic and renal function in diabetic mice.
Volume: 100
Issue: 9
Pages: 1169-1183
Publication
First Author: Gupte M
Year: 2012
Journal: Arterioscler Thromb Vasc Biol
Title: Angiotensin converting enzyme 2 contributes to sex differences in the development of obesity hypertension in C57BL/6 mice.
Volume: 32
Issue: 6
Pages: 1392-9
Publication
First Author: Bharadwaj MS
Year: 2011
Journal: Hypertension
Title: Angiotensin-converting enzyme 2 deficiency is associated with impaired gestational weight gain and fetal growth restriction.
Volume: 58
Issue: 5
Pages: 852-8
Publication
First Author: Haber PK
Year: 2014
Journal: Hypertension
Title: Angiotensin-converting enzyme 2-independent action of presumed angiotensin-converting enzyme 2 activators: studies in vivo, ex vivo, and in vitro.
Volume: 63
Issue: 4
Pages: 774-82
Publication
First Author: Wang Y
Year: 2015
Journal: Am J Physiol Endocrinol Metab
Title: Administration of 17β-estradiol to ovariectomized obese female mice reverses obesity-hypertension through an ACE2-dependent mechanism.
Volume: 308
Issue: 12
Pages: E1066-75
Publication
First Author: Ji H
Year: 2020
Journal: Hypertension
Title: Sex-Specific Modulation of Blood Pressure and the Renin-Angiotensin System by ACE (Angiotensin-Converting Enzyme) 2.
Volume: 76
Issue: 2
Pages: 478-487
Publication
First Author: Sriramula S
Year: 2015
Journal: Hypertension
Title: Brain-targeted angiotensin-converting enzyme 2 overexpression attenuates neurogenic hypertension by inhibiting cyclooxygenase-mediated inflammation.
Volume: 65
Issue: 3
Pages: 577-86
Publication
First Author: Zheng JL
Year: 2014
Journal: CNS Neurosci Ther
Title: Angiotensin converting enzyme 2/Ang-(1-7)/mas axis protects brain from ischemic injury with a tendency of age-dependence.
Volume: 20
Issue: 5
Pages: 452-9
Publication
First Author: Yamamoto K
Year: 2006
Journal: Hypertension
Title: Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II.
Volume: 47
Issue: 4
Pages: 718-26
Publication
First Author: Sahara M
Year: 2014
Journal: Cardiovasc Res
Title: Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation.
Volume: 101
Issue: 2
Pages: 236-46
Publication
First Author: Nakamura K
Year: 2008
Journal: Hypertens Res
Title: Candesartan ameliorates cardiac dysfunction observed in angiotensin-converting enzyme 2-deficient mice.
Volume: 31
Issue: 10
Pages: 1953-61
Publication  
First Author: Wang XL
Year: 2016
Journal: NPJ Aging Mech Dis
Title: Deficiency of angiotensin-converting enzyme 2 causes deterioration of cognitive function.
Volume: 2
Pages: 16024
Publication
First Author: Wu HT
Year: 2018
Journal: Exp Anim
Title: Loss of angiotensin converting enzyme II (ACE2) accelerates the development of liver injury induced by thioacetamide.
Volume: 67
Issue: 1
Pages: 41-49
Publication
First Author: Zhang C
Year: 2010
Journal: Proc Natl Acad Sci U S A
Title: Angiotensin-converting enzyme 2 attenuates atherosclerotic lesions by targeting vascular cells.
Volume: 107
Issue: 36
Pages: 15886-91
Publication
First Author: Song R
Year: 2012
Journal: Pediatr Res
Title: Ontogeny of angiotensin-converting enzyme 2.
Volume: 71
Issue: 1
Pages: 13-9
Publication
First Author: Shi TT
Year: 2018
Journal: Biochem Biophys Res Commun
Title: Angiotensin-converting enzyme 2 regulates mitochondrial function in pancreatic β-cells.
Volume: 495
Issue: 1
Pages: 860-866
Publication  
First Author: Yang M
Year: 2020
Journal: Front Pharmacol
Title: Liraglutide Attenuates Non-Alcoholic Fatty Liver Disease in Mice by Regulating the Local Renin-Angiotensin System.
Volume: 11
Pages: 432
Publication
First Author: Viveiros A
Year: 2021
Journal: Am J Physiol Heart Circ Physiol
Title: Sex differences in COVID-19: candidate pathways, genetics of ACE2, and sex hormones.
Volume: 320
Issue: 1
Pages: H296-H304
Publication  
First Author: Tada T
Year: 2023
Journal: JCI Insight
Title: Single-epitope T cell-based vaccine protects against SARS-CoV-2 infection in a preclinical animal model.
Volume: 8
Issue: 7
Publication
First Author: Crackower MA
Year: 2002
Journal: Nature
Title: Angiotensin-converting enzyme 2 is an essential regulator of heart function.
Volume: 417
Issue: 6891
Pages: 822-8
Publication  
First Author: Zou Z
Year: 2014
Journal: Nat Commun
Title: Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections.
Volume: 5
Pages: 3594
Publication
First Author: Zhong J
Year: 2010
Journal: Circulation
Title: Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction.
Volume: 122
Issue: 7
Pages: 717-28, 18 p following 728
Publication
First Author: Kassiri Z
Year: 2009
Journal: Circ Heart Fail
Title: Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction.
Volume: 2
Issue: 5
Pages: 446-55
Publication
First Author: Patel VB
Year: 2014
Journal: Hypertension
Title: Angiotensin-converting enzyme 2 is a critical determinant of angiotensin II-induced loss of vascular smooth muscle cells and adverse vascular remodeling.
Volume: 64
Issue: 1
Pages: 157-64
Publication
First Author: Cao X
Year: 2019
Journal: Lipids Health Dis
Title: Angiotensin-converting enzyme 2 regulates endoplasmic reticulum stress and mitochondrial function to preserve skeletal muscle lipid metabolism.
Volume: 18
Issue: 1
Pages: 207
Publication
First Author: Osterreicher CH
Year: 2009
Journal: Hepatology
Title: Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice.
Volume: 50
Issue: 3
Pages: 929-38
Publication
First Author: He H
Year: 2015
Journal: Cell Transplant
Title: Mesenchymal Stem Cells Overexpressing Angiotensin-Converting Enzyme 2 Rescue Lipopolysaccharide-Induced Lung Injury.
Volume: 24
Issue: 9
Pages: 1699-715
Publication
First Author: Xiao F
Year: 2014
Journal: PLoS One
Title: Characterization of angiotensin-converting enzyme 2 ectodomain shedding from mouse proximal tubular cells.
Volume: 9
Issue: 1
Pages: e85958
Publication  
First Author: Wysocki J
Year: 2019
Journal: Biomolecules
Title: Novel Variants of Angiotensin Converting Enzyme-2 of Shorter Molecular Size to Target the Kidney Renin Angiotensin System.
Volume: 9
Issue: 12
Publication
First Author: Xia H
Year: 2011
Journal: PLoS One
Title: ACE2-mediated reduction of oxidative stress in the central nervous system is associated with improvement of autonomic function.
Volume: 6
Issue: 7
Pages: e22682
Publication      
First Author: Wang J
Year: 2020
Journal: FASEB J
Title: The ACE2-deficient mouse: A model for a cytokine storm-driven inflammation.
Publication
First Author: Clotet S
Year: 2016
Journal: J Hypertens
Title: Gonadectomy prevents the increase in blood pressure and glomerular injury in angiotensin-converting enzyme 2 knockout diabetic male mice. Effects on renin-angiotensin system.
Volume: 34
Issue: 9
Pages: 1752-65
Publication  
First Author: Romero MJ
Year: 2023
Journal: Front Immunol
Title: Direct endothelial ENaC activation mitigates vasculopathy induced by SARS-CoV2 spike protein.
Volume: 14
Pages: 1241448
Publication  
First Author: Mahajan S
Year: 2023
Journal: Front Neurosci
Title: Knockout of angiotensin converting enzyme-2 receptor leads to morphological aberrations in rodent olfactory centers and dysfunctions associated with sense of smell.
Volume: 17
Pages: 1180868
Publication
First Author: Feng Y
Year: 2010
Journal: Circ Res
Title: Brain-selective overexpression of human Angiotensin-converting enzyme type 2 attenuates neurogenic hypertension.
Volume: 106
Issue: 2
Pages: 373-82
Publication
First Author: Wang Y
Year: 2021
Journal: FASEB J
Title: A pressor dose of angiotensin II has no influence on the angiotensin-converting enzyme 2 and other molecules associated with SARS-CoV-2 infection in mice.
Volume: 35
Issue: 3
Pages: e21419
Publication
First Author: Bourgonje AR
Year: 2020
Journal: J Pathol
Title: Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).
Volume: 251
Issue: 3
Pages: 228-248
Publication
First Author: Fang Y
Year: 2019
Journal: QJM
Title: Angiotensin-converting enzyme 2 attenuates inflammatory response and oxidative stress in hyperoxic lung injury by regulating NF-κB and Nrf2 pathways.
Volume: 112
Issue: 12
Pages: 914-924
Publication
First Author: Nozato S
Year: 2019
Journal: Clin Sci (Lond)
Title: Angiotensin 1-7 alleviates aging-associated muscle weakness and bone loss, but is not associated with accelerated aging in ACE2-knockout mice.
Volume: 133
Issue: 18
Pages: 2005-2018
Publication  
First Author: Xuan X
Year: 2018
Journal: Metabolism
Title: Activation of ACE2/angiotensin (1-7) attenuates pancreatic β cell dedifferentiation in a high-fat-diet mouse model.
Volume: 81
Pages: 83-96
Publication
First Author: Takeshita H
Year: 2018
Journal: J Cachexia Sarcopenia Muscle
Title: Angiotensin-converting enzyme 2 deficiency accelerates and angiotensin 1-7 restores age-related muscle weakness in mice.
Volume: 9
Issue: 5
Pages: 975-986
Publication  
First Author: Saá P
Year: 2022
Journal: J Clin Invest
Title: Frequent detection but lack of infectivity of SARS-CoV-2 RNA in presymptomatic, infected blood donor plasma.
Volume: 132
Issue: 17
Publication
First Author: Pan X
Year: 2018
Journal: Cell Metab
Title: FGF21 Prevents Angiotensin II-Induced Hypertension and Vascular Dysfunction by Activation of ACE2/Angiotensin-(1-7) Axis in Mice.
Volume: 27
Issue: 6
Pages: 1323-1337.e5
Publication
First Author: Fairweather SJ
Year: 2012
Journal: Biochem J
Title: Intestinal peptidases form functional complexes with the neutral amino acid transporter B(0)AT1.
Volume: 446
Issue: 1
Pages: 135-48
Publication
First Author: Singer D
Year: 2009
Journal: J Biol Chem
Title: Orphan transporter SLC6A18 is renal neutral amino acid transporter B0AT3.
Volume: 284
Issue: 30
Pages: 19953-60
Publication
First Author: Thatcher SE
Year: 2014
Journal: Arterioscler Thromb Vasc Biol
Title: Angiotensin-converting enzyme 2 decreases formation and severity of angiotensin II-induced abdominal aortic aneurysms.
Volume: 34
Issue: 12
Pages: 2617-23
Publication
First Author: Thatcher SE
Year: 2011
Journal: Arterioscler Thromb Vasc Biol
Title: Angiotensin-converting enzyme 2 deficiency in whole body or bone marrow-derived cells increases atherosclerosis in low-density lipoprotein receptor-/- mice.
Volume: 31
Issue: 4
Pages: 758-65